KLAUS ELDRUP-JORGENSEN, M.D.
DirectorKlaus Eldrup Jorgensen, M.D. assumed the position as interim CEO of Osteologix in July 2003 and in November 2003 the role as Executive Chairman of the Board of directors. Dr. Klaus Eldrup Jorgensen has worked as a commercial executive at corporate level in several international pharmaceutical companies as well as in venture-financed companies for many years. He has held senior positions in a number of companies, including Novo Nordisk A/S, Dako A/S and Nordic Bioscience A/S. Dr. Klaus Eldrup Jorgensen is currently one of the founders and the CEO of the high-tech Company ISG A/S. Dr. Klaus Eldrup Jorgensen presently serves as chairman for two Copenhagen based biotech companies, Cartificial A/S and Cantion A/S, and as advisor to several biotech venture funds.